Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAAPrevia
2019-004439-22Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Tranexamic acid plus prophylactic uterotonic with Placebo plus prophylactic uterotonic (2 arms). Primary endpoint: Incidence of red blood cell transfusion. Started Jan 2020; status: active.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on 2019-004439-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004439-22.